- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT00608855
Percutaneous Cryoablation in Treating Patients With Painful Bone Metastases
Percutaneous US and CT-guided Cryoablation of Painful Metastases Involving Bone: A Feasibility Study
RATIONALE: Percutaneous cryoablation may help relieve pain caused by bone metastases.
PURPOSE: This clinical trial is studying the side effects and how well percutaneous cryoablation works in treating patients with painful bone metastases.
Studieöversikt
Status
Intervention / Behandling
Detaljerad beskrivning
OBJECTIVES:
- To confirm the safety of percutaneous cryoablation in the palliative treatment of patients with painful bone metastases.
- To determine the benefits of cryoablation of painful bone metastases by assessing pain intensity using a standardized Cleeland Brief Pain Inventory (BPI) and quality of life using a standardized SF-8 both before and after treatment.
- To determine the secondary benefits of cryoablation of painful bone metastases by assessing change in analgesic use following therapy.
- To determine the level of anesthesia required for cryoablation with a baseline level of conscious sedation planned for each treatment.
OUTLINE: This is a multicenter study.
Patients undergo percutaneous cryoablation to one or two sites of metastatic disease using the Endocare Cryocare system. Patients with a good initial response to treatment (≥ 2 decrease in pain intensity rating on the Brief Pain Inventory) who develop recurrent pain at the same site or a new painful site ≥ 1 month after initial treatment may undergo one additional cryoablation treatment.
Patients complete pain and quality of life questionnaires periodically.
After completion of study treatment, patients are followed periodically for 2 years.
Studietyp
Inskrivning (Förväntat)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Florida
-
Jacksonville, Florida, Förenta staterna, 32224
- Mayo Clinic - Jacksonville
-
-
Michigan
-
Ann Arbor, Michigan, Förenta staterna, 48109-0942
- University of Michigan Comprehensive Cancer Center
-
Detroit, Michigan, Förenta staterna, 48201-1379
- Barbara Ann Karmanos Cancer Institute
-
-
Minnesota
-
Rochester, Minnesota, Förenta staterna, 55905
- Mayo Clinic Cancer Center
-
-
New York
-
New York, New York, Förenta staterna, 10021
- Memorial Sloan-Kettering Cancer Center
-
New York, New York, Förenta staterna, 10016
- NYU Cancer Institute at New York University Medical Center
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Förenta staterna, 19104-4283
- Abramson Cancer Center of the University of Pennsylvania
-
-
Rhode Island
-
Providence, Rhode Island, Förenta staterna, 02912
- Brown University School of Medicine
-
-
Wisconsin
-
Madison, Wisconsin, Förenta staterna, 53792-6164
- University of Wisconsin Paul P. Carbone Comprehensive Cancer Center
-
Milwaukee, Wisconsin, Förenta staterna, 53215
- Vince Lombardi Cancer Clinic at Aurora St. Luke's Medical Center
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
DISEASE CHARACTERISTICS:
Histologically or cytologically confirmed metastatic solid tumor involving or abutting bone (index lesion)
- If the nature of the metastatic disease has been previously documented, index lesion to be treated does not require further documentation (i.e., biopsy)
Pain either refractory to standard care (chemotherapy, radiotherapy, surgery, or analgesics) or patient is considered a poor candidate for conventional therapies
- Radiation oncology consult is required if the patient is considered clinically to be a candidate for conventional palliative radiotherapy
- Surgical oncology consult is required if the patient is considered clinically to be a candidate for conventional surgical treatment or is considered at risk for complications resulting from potential fracture
Initial pain score ≥ 4 on a scale of 0-10 for the question "Please rate your pain by circling the one number that best describes your pain at its worst in the past 24 hours" on the Cleeland Brief Pain Inventory
- Pain from ≤ 2 sites of metastatic disease
- No lesions with evidence for impending fracture involving a weight-bearing bone (> 50% loss of cortical bone at the site)
PATIENT CHARACTERISTICS:
- Life expectancy ≥ 2 months
- Platelet count ≥ 75,000/mm³
- ANC > 1,500/mm³ (for patients who have recently been treated with chemotherapy)
- INR ≤ 1.2
- Not pregnant or nursing
- Negative pregnancy test
PRIOR CONCURRENT THERAPY:
- More than 3 weeks since prior radiotherapy
- More than 3 weeks since initiation of a new chemotherapy regimen, including bisphosphonates
- More than 7 days since prior antiplatelet medications or clopidogrel
- More than 3 days since prior acetylsalicylic acid (aspirin), ibuprofen, or other NSAIDs
- No prior treatment of the portion of a lesion within 0.5 cm of the spinal cord or brain, within 0.5 cm of a large abdominal vessel such as the aorta or inferior vena cava, or within 1 cm of bowel or bladder
- No prior radiofrequency ablation for pain palliation of the same lesion
- No concurrent regular or low molecular weight heparin or other anticoagulants
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Maskning: Ingen (Open Label)
Vad mäter studien?
Primära resultatmått
Resultatmått |
---|
Average difference in pre- and post-treatment worst pain score in a 24-hour period at week 8
|
Sekundära resultatmått
Resultatmått |
---|
Average difference in pre- and post-treatment worst pain score in a 24-hour period, average pain score, and pain relief score at 6, 12, and 24 months
|
Average amount of pain per patient over the observation period as represented by the area under the curve (AUC) constructed from weekly pain scores on a visual-analogue scale using a score of 0-10
|
Percentage of patients who are able to reduce analgesic medications
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Studiestol: Matthew R. Callstrom, MD, PhD, Mayo Clinic
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- MC03C3
- MAYO-MC03C3
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Smärta
-
Korea University Anam HospitalKorea UniversityAvslutadSmärtmätning | Visual Analog Pain Scale
-
Alanya Alaaddin Keykubat UniversityAvslutadSterilisering, Tubal | Visual Analog Pain Scale
-
Turkish Ministry of Health, Kahramanmaras Provincial...RekryteringVisual Analog Pain ScaleKalkon
-
Ankara UniversityAvslutadSmärtmätning | Visual Analog Pain ScaleKalkon
-
East Carolina UniversityIndragen
-
University Hospital, GrenobleAvslutadDövhet | Visual Analog Pain ScaleFrankrike
-
Moens MaartenRekryteringMisslyckad Ryggkirurgi Syndrom | Persistent Spinal Pain Syndrome Typ 2Belgien
-
Moens MaartenVrije Universiteit BrusselRekryteringRyggmärgsstimulering | Persistent Spinal Pain Syndrome Typ 2Belgien
-
Örebro University, SwedenAvslutadPostoperativ smärtintensitet | Rescue Pain KravSverige
-
Wake Forest University Health SciencesRekryteringPhantom Limb Pain (PLP)Förenta staterna
Kliniska prövningar på enkätadministration
-
Catholic University of the Sacred HeartAvslutadLivskvalité | Kirurgiskt sår | Biopsisår | Läka kirurgiska sårItalien
-
Korea United Pharm. Inc.AvslutadDiabetes mellitus, typ 2Korea, Republiken av
-
Korea United Pharm. Inc.AvslutadGERDKorea, Republiken av
-
Boston UniversityNational Heart, Lung, and Blood Institute (NHLBI)Avslutad
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...The Leeds Teaching Hospitals NHS Trust; University of Leeds; European Organisation... och andra samarbetspartnersHar inte rekryterat ännuCancer | Palliativ vård | ÖverlevnadUngern, Italien, Frankrike, Storbritannien, Nederländerna, Spanien, Estland, Serbien, Litauen, Slovenien, Albanien, Österrike, Belgien, Bulgarien, Kroatien, Cypern, Tjeckien, Danmark, Finland, Georgien, Tyskland, Grekland, Irland, Lett... och mer
-
Lukas Biomedical Inc.Virginia Contract Research Organization Co., Ltd.RekryteringHepatocellulärt karcinomTaiwan
-
University of EdinburghBritish Heart FoundationAvslutad
-
Fondazione Don Carlo Gnocchi OnlusMeyer Children's Hospital IRCCS; Fondazione Don Carlo Gnocchi ONLUS - Centro...Rekrytering
-
Istituto Ortopedico GaleazziAvslutad
-
Gumi Cha Medical CenterAvslutadKroniska njursjukdomarKorea, Republiken av